Tumor necrosis factor receptor p55 controls the severity of arthritis in experimental Yersinia enterocolitica infection

Arthritis and Rheumatism

Volumn 42, Issue 8, 1999, Pages 1662-1672

  Zhao, Yi Xue ^a   Zhang, Hongwei ^a   Chiu, Basil ^a   Payne, Ursula ^a   Inman, Robert D ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY BURST; YERSINIA ENTEROCOLITICA;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, CD; ARTHRITIS, INFECTIOUS; B-LYMPHOCYTES; BLOOD BACTERICIDAL ACTIVITY; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; INTERFERON TYPE II; INTERLEUKIN-10; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RESPIRATORY BURST; SEVERITY OF ILLNESS INDEX; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS;

EID: 0033502710     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199908)42:8<1662::AID-ANR15>3.0.CO;2-8     Document Type: Article

References (55)

1. Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med 1989;321:16-24.
2. Bouza E, Dominguez A, Meseguer M, Buzon L, Boixeda M, Revillo MJ, et al. Yersinia enterocolitica septicemia. Am J Clin Pathol 1980;74:404-9.
3. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983;309:1606-15.
4. Inman RD, Scofield RH. Etiopathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 1994;6:360-70.
5. Thomson GTD, DeRubeis DA, Hodge MA, Rajanayagam C, Inman RD. Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort. Am J Med 1995;98:13-21.
6. Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heino K, et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med 1989;320:216-21.
7. Hammer M, Zeidler H, Klimsa S, Heesemann J. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum 1990;33:1795-800.
8. Gaston JS, Life PF, Granfors K, Merilahti Palo R, Bailey L, Consalvey S. Synovial T lymphocyte recognition of organisms that trigger reactive arthritis. Clin Exp Immunol 1989;76:348-53.
9. Viner NJ, Bailey LC, Life PF, Bacon PA, Gaston JSH. Isolation of Yersinia-specific T cell clones from the synovial membrane and synovial fluid of a patient with reactive arthritis. Arthritis Rheum 1991;34:1151-7.
10. Granfors K, Toivanen A. IgA-anti-Yersinia-antibodies in Yersinia triggered reactive arthritis. Ann Rheum Dis 1986;45:561-5.
11. Toivanen A, Granfors K, Lahesmaa-Rantala R, Leino R, Stahlberg T, Vuento R. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev 1985;86:47-70.
12. Autenrieth IB, Beer M, Bohn E, Kaufmann SHE, Heeseman J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun 1994;62:2590-9.
13. Bohn E, Heesemann J, Ehlers S, Autenrieth IB. Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica. Infect Immun 1994;62:3027-32.
14. Autenrieth IB, Heesemann J. In vivo neutralization of tumor necrosis factor alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica in mice. Med Microbiol Immunol 1992; 181:333-8.
15. + T cells. J Immunol 1996;156:1458-68.
16. Buedack SSA, Knieschies E, Rollinghoff M, Beuscher HU. Tumor necrosis factor-alpha expression induced by anti-YopB antibodies coincides with protection against Yersinia enterocolitica infection in mice. Med Microbiol Immunol 1997;185:223-9.
17. Bemelmans MHA, van Tits LJH, Buurman WA. Tumor necrosis factor. Crit Rev Immunol 1996;16:1-11.
18. Eigler A, Sinha B, Hartmann G, Endres S. Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 1997; 18:487-92.
19. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
20. phox-/- and TRp55-/-mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 1997;7:419-32.
21. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
22. Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 1996;157:827-35.
23. Bohn E, Schmitt E, Bielfeldt C, Noll A, Schulte R, Autenrieth I. Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains. Infect Immun 1998;66:2213-20.
24. Pfeffer K, Matsuyama Y, Kundig TM, Wakeham A, Kishihara K, Shahinian A, et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993;73:457-67.
25. Gripenberg-Lerche C, Toivanen P. Yersinia associated arthritis in SHR rats: effect of the microbial status of the host. Ann Rheum Dis 1993:52:223-8.
26. Roggenkamp A, Neuberger HR, Flugel A, Schmoll T, Heesemann J. Substitution of two histidine residues in Yad A protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence. Mol Microbiol 1995;16:1207-19.
27. Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Ann Biochem 1982;126:131-8.
28. Inman RD, Johnston MEA, Klein MH. Analysis of serum and synovial fluid IgA in Reiter's syndrome and reactive arthritis. Clin Immun Immunopathol 1987;43:195-203.
29. + T lymphocytes. Cell Immunol 1995;161:28-33.
30. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
31. Zhao Y-X, Abdelnour A, Holmdahl R, Tarkowski A. Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J Immunol 1995;155:2067-76.
32. Hu-Li J, Ohara J, Watyson C, Tsang W, Paul WE. Derivation of a T cell line thai is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J Immunol 1989;142:800-7.
33. - T cells. J Immunol 1997;158:3081-9.
34. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue E. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J Immunol 1993;150:888-95.
35. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J Immunol 1988;141:2407-12.
36. Gallin JI, Buescher ES, Seligmann BE, Nath J, Gaither T, Katz P. NIH conference: recent advances in chronic granulomatous disease. Ann Intern Med 1983;99:657-74.
37. Hir ML, Bluethmann H, Kosco-Vilbois MH, Muller M, di Padova F, Moore M, et al. Differentiation of follicular dendritic cells and full antibody responses required tumor necrosis factor receptor-1 signaling. J Exp Med 1996;193:2367-72.
38. Hill JL, Yu DT. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun 1987;55:721-6.
39. Merilahti-Palo R, Gripenberg-Lerche C, Soderstrom K-O, Toivanen P. Long term follow up of SHR rats with experimental yersinia associated arthritis. Ann Rheum Dis 1992;51:91-6.
40. Gaede KI, Heesemann J. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype 08 for Lewis rats. Infect Immun 1995;63:714-9.
41. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983;309:1606-15.
42. Tufano MA, Rossano F, Catalanotti P, Liguori G, Marinelli A, Baroni A, et al. Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res Microbiol 1994;145: 297-307.
43. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994;6:458-66.
44. Mosmann T, Moore K. The role of IL-10 in cross-regulation of Th1 and Th2 responses. Immunol Today 1991;12:A49-53.
45. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
46. Feldmann M, Brennan F, Maini R. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397-440.
47. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;20:9784-8.
48. Thomas BM, Mundy GR, Chambers TJ. Tumour necrosis factor alpha and beta induce osteoblastic cells to stimulate osteoclast bone resorption. J Immunol 1987;138:775-9.
49. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
50. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumor necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
51. Braun J, Yin Z, Krause A, Liu L, Spiller I, Sieper J. Peripheral blood cells of reactive arthritis patients secrete more IL-10 and less TNF-α than patients with Lyme or rheumatoid arthritis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S79.
52. Höhler T, Schäper T, Schneider PM, Meyer zum Büschenfelde K-H, Märker-Hermann E. Association of different tumor necrosis factor α promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998;41:1489-92.
53. Inman RD, Chiu B. Comparative microbicidal activity of synovial fluid on arthritogenic organisms. Clin Exp Immunol 1996;104: 80-5.
54. Inman RD, Chiu B. Synoviocyte-packaged Chlamydia trachomatis induces a chronic aseptic arthritis. J Clin Invest 1998;102:1776-82.
55. Hermann E, Fleischer B, Mayet WJ, Poralla T, Meyer zum Buschenfelde KH. Response of synovial fluid T cell clones to Yersinia enterocolitica antigens in patients with reactive Yersinia arthritis. Clin Exp Immunol 1989;75:365-70.